Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

LETROZOLE

LETROZOLE

Standard Dose
2.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LETROZOLE is listed in Drugs@FDA under application 211717 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LETROZOLE Form and strength TABLET;ORAL - 2.5MG Sponsor EUGIA PHARMA Submission history Latest submission status date: 2025-07-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview LETROZOLE is listed in Drugs@FDA under application 211717 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LETROZOLE Form and strength TABLET;ORAL - 2.5MG Sponsor EUGIA PHARMA Submission history Latest submission status date: 2025-07-02 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
LETROZOLE (LETROZOLE) | Drug Monograph | MedicHelpline